Dyne Therapeutics (DYN) Non-Current Assets (2019 - 2026)

Dyne Therapeutics' Non-Current Assets history runs 8 years deep, the most recent figure standing at $58.9 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 86.64% year-over-year to $58.9 million; the TTM figure through Mar 2026 stood at $182.3 million (up 40.75% YoY), while the FY2025 annual figure was $31.2 million, down 2.36% from the prior year.
• Non-Current Assets was $58.9 million for Q1 2026 at Dyne Therapeutics, up from $31.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $60.8 million in Q3 2025 to a low of $31.0 million in Q2 2025.
• Historically, Non-Current Assets has averaged $39.0 million across 5 years, with a median of $37.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 833.05% in 2022, then decreased 13.42% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $40.7 million in 2022, then dropped by 12.33% to $35.7 million in 2023, then dropped by 10.51% to $32.0 million in 2024, then decreased by 2.36% to $31.2 million in 2025, then soared by 88.86% to $58.9 million in 2026.
• The last three Non-Current Assets figures came in at $58.9 million (Q1 2026), $31.2 million (Q4 2025), and $60.8 million (Q3 2025), per Business Quant data.